Markets Reprice Fed Rate Path Hot Inflation Data Dims Cut Expectations Through 2027 AnheuserBusch InBev Shares Slip as Quarterly Sales Miss Market Expectations GlobalFoundries Establishes Dedicated Quantum Technology Unit Signaling Strategic Pivot in Semiconductor Landscape Carson Block Reconsiders India Fund Strategy Amid AIDriven Investment Shift Oura Ring Maker Targets Over 9 Billion Valuation in Planned US IPO SpaceX IPO Speculation Nvidia Earnings and Bezos AI Remarks Lead Morning Market Brief ABX Q1 2026 Earnings EPS Meets Estimates but Stock Declines on Narrow Surprise SEED Q4 2011 Earnings EPS Surges 117 Above Estimates Strong Operational Execution NUVB Q1 2026 Earnings Narrow EPS Beat Amid No Revenue and Stock Decline Mission Produce Q1 2026 Earnings EPS Beat Offset by Revenue Uncertainty and Stock Decline ARBE Q4 2025 Earnings Narrow EPS Beat Amid Market Skepticism TCBK Q1 2026 Earnings Earnings Beat Estimates Amid Solid Operational Performance Megan Holdings MGN Gains 297 Testing Key Resistance at 017 Frontier Group Holdings ULCC Edges Higher as UltralowCost Carrier Navigates Competitive Pressures Cellebrite CLBT Gains 175 as Support Holds Resistance in Focus Jasper Therapeutics JSPR Hovers Near Support as Biotech Sentiment Remains Cautious Renatus Tactical Acquisition Corp I Unit RTACU Edges Higher as Trading Remains Tight Greencore FirstHalf Profits Weighed Down by Bakkavor Acquisition Costs TBBK Q1 2026 Earnings EPS Beats Estimates by 342 Shares Edge Higher HCW Biologics HCWB Plunges Over 23 as Selling Pressure Intensifies Ormat Technologies Q1 2026 Earnings EPS Surges 403 Above Estimates Stock Slips INFY Q1 2026 Earnings Strong EPS Beat Amidst Market Caution SSSSL Q1 2026 Earnings Massive EPS Surprise on Investment Gains Bond Price Edges Lower Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises Offerpad Solutions Inc OPAD Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Controls Drive Beat ULTA Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains on Resilient Demand ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control